Comments
Dr Reddy’s Laboratories has received Establishment Inspection Report (EIR) from the US Food & Drug Administration (USFDA) for its API manufacturing facility (CTO-6) in Srikakulam, Andhra Pradesh.
“The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is closed,” the Hyderabad-based company said in a release.
The company’s scrip lost 0.42 per cent on the Bombay Stock Exchange on Friday to end at ₹6669.75
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.